Jin Jin Selected Research

Joint Diseases (Joint Disease)

6/2021	Mid-Term Outcome of Total Hip Arthroplasty in Patients With Progressive Pseudorheumatoid Dysplasia.
2/2015	[Postoperative complications and revision surgery following primary total knee arthroplasty after midterm follow-up].
3/2012	[Effectiveness of multiple joint arthroplasty in treating lower limb joint disease].
6/2008	[Perioperative management in hemophilic arthropathy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin Jin Research Topics

Disease

56	Neoplasms (Cancer) 03/2024 - 09/2006
13	Inflammation (Inflammations) 03/2024 - 05/2013
11	Infections 05/2021 - 09/2002
11	Pain (Aches) 01/2020 - 08/2005
10	Osteoarthritis 01/2020 - 09/2002
9	Body Weight (Weight, Body) 01/2023 - 01/2012
8	Oncogenic osteomalacia 02/2024 - 11/2013
7	Rheumatoid Arthritis 03/2024 - 09/2002
6	Breast Neoplasms (Breast Cancer) 02/2019 - 01/2014
5	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2017
5	Virus Diseases (Viral Diseases) 01/2023 - 01/2011
5	Arthritis (Polyarthritis) 01/2017 - 08/2005
4	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 01/2018
4	Fibrosis (Cirrhosis) 03/2023 - 06/2019
4	Tuberculosis (Tuberculoses) 01/2023 - 01/2014
4	Asthma (Bronchial Asthma) 01/2023 - 01/2018
4	Colitis 01/2022 - 01/2015
4	Joint Diseases (Joint Disease) 06/2021 - 06/2008
3	Lymphoma (Lymphomas) 03/2024 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 07/2013
3	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 10/2023 - 01/2022
3	Idiopathic Pulmonary Fibrosis 01/2023 - 01/2019
3	Hypophosphatemia 11/2022 - 11/2013
3	Congenital Abnormalities (Deformity) 06/2021 - 08/2005
3	Osteonecrosis (Kienbock's Disease) 01/2021 - 01/2013
3	Leukemia 01/2021 - 01/2018
3	Anemia 04/2019 - 03/2012
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 02/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 03/2016
3	Adenocarcinoma 01/2019 - 07/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2018 - 09/2014
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2013
3	Wounds and Injuries (Trauma) 05/2011 - 05/2008
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2024 - 04/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 01/2018
2	Osteoporosis 01/2024 - 03/2004
2	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2018
2	Carcinogenesis 11/2023 - 11/2013
2	Rare Diseases (Rare Disease) 11/2022 - 06/2021
2	Multiple Myeloma 11/2022 - 09/2021
2	Adenocarcinoma of Lung 03/2022 - 01/2021
2	Genetic Risk Score 01/2022 - 12/2021
2	Obesity 01/2022 - 01/2021
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2022
2	Hypersensitivity (Allergy) 11/2021 - 02/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2013
12	Proteins (Proteins, Gene)FDA Link 06/2024 - 01/2008
9	Fibroblast Growth Factor-23IBA 10/2023 - 11/2013
7	CytokinesIBA 02/2023 - 01/2015
5	Chimeric Antigen ReceptorsIBA 03/2024 - 10/2019
5	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 02/2010
5	Phosphorus (Red Phosphorus)IBA 01/2020 - 09/2012
5	AntigensIBA 08/2019 - 02/2010
5	Bevacizumab (Avastin)FDA Link 08/2016 - 07/2013
4	Therapeutic UsesIBA 07/2023 - 05/2012
4	SteroidsIBA 01/2023 - 01/2013
4	fibrin fragment D (D-dimer)IBA 05/2021 - 11/2018
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 01/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2015 - 09/2002
3	Interferon Type IIBA 01/2023 - 03/2014
3	Hormones (Hormone)IBA 11/2022 - 06/2012
3	UbiquitinIBA 01/2022 - 01/2018
3	Monoclonal AntibodiesIBA 01/2022 - 10/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 09/2021 - 01/2008
3	parecoxibIBA 01/2020 - 01/2018
3	InflammasomesIBA 01/2020 - 01/2020
3	Ado-Trastuzumab EmtansineIBA 01/2018 - 12/2017
2	CalciumIBA 02/2024 - 10/2023
2	Peptides (Polypeptides)IBA 01/2024 - 05/2010
2	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2019
2	Omalizumab (Xolair)FDA Link 06/2023 - 01/2023
2	Immunoglobulin E (IgE)IBA 06/2023 - 01/2023
2	Phosphates (Orthophosphate)IBA 01/2023 - 11/2022
2	Long Noncoding RNAIBA 12/2022 - 03/2022
2	Troponin IIBA 12/2022 - 12/2019
2	Interleukin-10 (Interleukin 10)IBA 11/2022 - 01/2017
2	Capsules (Microcapsules)IBA 06/2022 - 01/2017
2	Ezetimibe (Zetia)FDA Link 01/2022 - 01/2021
2	Volatile Fatty AcidsIBA 01/2022 - 01/2021
2	Chemokine ReceptorsIBA 01/2022 - 01/2020
2	astegolimabIBA 01/2022 - 10/2021
2	AlbuminsIBA 01/2022 - 04/2019
2	Orlistat (Xenical)FDA Link 01/2022 - 01/2021

Therapy/Procedure

19	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2022 - 09/2002
15	Therapeutics 03/2024 - 08/2014
8	Immunotherapy 01/2024 - 01/2017
8	Hip Replacement Arthroplasty (Total Hip Replacement) 04/2023 - 02/2005
6	Arthroplasty 01/2018 - 08/2005
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
3	Analgesia 11/2018 - 01/2018
3	Replacement Arthroplasty 02/2016 - 03/2011
3	Aftercare (After-Treatment) 06/2015 - 03/2010
3	Debridement 05/2011 - 09/2002
3	Prostheses and Implants (Prosthesis) 06/2009 - 09/2002
2	Length of Stay 02/2024 - 11/2018
2	Liver Transplantation 02/2024 - 01/2023
2	Ligation 01/2022 - 01/2022